Cargando…
A Review on Increasing the Targeting of PAMAM as Carriers in Glioma Therapy
Glioma is an invasive brain cancer, and it is difficult to achieve desired therapeutic effects due to the high postoperative recurrence rate and limited efficacy of drug therapy hindered by the biological barrier of brain tissue. Nanodrug delivery systems are of great interest, and many efforts have...
Autores principales: | Li, Xingyue, Ta, Wenjing, Hua, Ruochen, Song, Jihong, Lu, Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599152/ https://www.ncbi.nlm.nih.gov/pubmed/36289715 http://dx.doi.org/10.3390/biomedicines10102455 |
Ejemplares similares
-
Customizable Dual-Fluorescent Nanoparticles for Tracing and Quantifying of Cell Transport
por: Ta, Wenjing, et al.
Publicado: (2023) -
SRL-Coated PAMAM Dendrimer Nano-Carrier for Targeted Gene Delivery to the Glioma Cells and Competitive Inhibition by Lactoferrin
por: zarebkohan, Amir, et al.
Publicado: (2016) -
Recent Findings Concerning PAMAM Dendrimer Conjugates with Cyclodextrins as Carriers of DNA and RNA
por: Arima, Hidetoshi, et al.
Publicado: (2009) -
Photosensitizer and peptide-conjugated PAMAM dendrimer for targeted in vivo photodynamic therapy
por: Narsireddy, Amreddy, et al.
Publicado: (2015) -
A novel RGDyC/PEG co-modified PAMAM dendrimer-loaded arsenic trioxide of glioma targeting delivery system
por: Lu, Yanping, et al.
Publicado: (2018)